Vildagliptin, a dipeptidyl peptidase-IV inhibitor improves model-assessed beta-cell function in patients with type 2 diabetes

A. Mari, W.M. Sallas, Y.L. He, C. Watson, M. Ligueros-Saylan, B.E. Duning, Carolyn F. Deacon, Jens Juul Holst, J.E. Foley

334 Citationer (Scopus)
OriginalsprogEngelsk
TidsskriftJ. Clin. Endocrinol. Metab.
Udgave nummer90
Sider (fra-til)4888-4894
StatusUdgivet - 2005

Citationsformater